I hERG ) amplitude (responsible for rapid delayed rectifier K + current)
Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably
How GLP-1 Works in the Body To understand their impact, it helps to look at how GLP-1 functions naturally
Free fatty acid receptors in health and disease
doi: 10.1016/j.neuropharm.2018.01.040